Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

PaperCitations, authors & open-access status

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 58 citations, 2022 year and hybrid oa status.

58
Citations
2022
Year
hybrid
OA Status

Related on ScholarIQ

Daphne S. Bakker
Author
Judith L. Thijs
Author
Allergy
Journal
Dermatology and Skin Diseases
Topic
Dermatology and Skin Diseases
Topic
Psoriasis: Treatment and Pathogenesis
Topic
470M+ articles · free account